Sunil Dhaliwal

Sunil Dhaliwal, founder of Amplify, and Mike Dauber, a partner since 2014, delve into their venture strategies focusing on outliers in tech and biotech. They discuss the evolution of the venture capital landscape, emphasizing the shift in supporting technical founders. The duo also shares insights from their recent $900 million fundraise and the launch of Amplify Bio, revealing their commitment to long-term investments in life sciences. Their approach champions decentralized decision-making, fostering innovative leaders in AI and cloud infrastructure.

Sunil Dhaliwal, a seasoned venture capitalist and founding partner of Amplify Partners, shares insightful perspectives on the intricacies of startup sales leadership. He discusses the vital traits required for success, such as adaptability and effective communication. Dhaliwal highlights how the role of sales leaders evolves with a company's growth stages and emphasizes the importance of aligning board presentations with core metrics. He also explores emerging tech trends and the significance of self-awareness for career satisfaction.

Brandon White, co-founder of Axiom, discusses groundbreaking AI models that replace animal testing in drug development, making the process quicker and more humane. Stefan Strine from the Cleveland Clinic highlights their strategic investments in AI and quantum computing for healthcare innovation. Sunil Dhaliwal of Amplify Partners shares insights on the rise of computational biologists and how they drive AI integration in biotech. Together, they explore the ethical implications and future potential of AI in transforming medicine and improving patient outcomes.